Literature DB >> 6385315

Metabolism during hepatic transplantation: indicators of allograft function.

J J Fath, N L Ascher, F N Konstantinides, J Bloomer, H Sharp, J S Najarian, F B Cerra.   

Abstract

In an attempt to determine the initial function of hepatic allografts, several metabolic indicators of hepatic function were studied intraoperatively in 12 cases of hepatic transplantation. The operation was divided into three sampling periods: baseline, anhepatic, and reperfusion. During the baseline period plasma lactate levels rose at 2.6 mmol/L/hr and continued to rise at a similar rate during the anhepatic period. Baseline period total free plasma amino acid levels (TFPAA) rose at a moderate rate of 0.4 mmol/L/hr. During the anhepatic period TFPAA levels rose at a fivefold greater rate than during baseline (p less than 0.01). The ability of the hepatic allograft to reduce abnormal levels of TFPAA and lactate during the reperfusion period was associated with reduced morbidity in the first 48 hours after transplantation. Intraoperative clearance of accumulated TFPAA is currently the best means of assessing initial allograft function. Elevated preoperative total serum bilirubin levels were also associated with increased early morbidity in hepatic transplant recipients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6385315

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  15 in total

1.  Disturbance of plasma thyroid hormone levels after experimental liver transplantation. Is there an association with primary graft nonfunction?

Authors:  C D Oakland; L Darge; R Hickman
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

2.  Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience.

Authors:  Cataldo Doria; Lucio Mandalá; Victor L Scott; Salvatore Gruttadauria; Ignazio R Marino
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  Changes in plasma concentrations of free amino acids during and after the anhepaic period.

Authors:  K Irita; H Okamoto; H Inoue; M Umeki; S Inaba; S Taniguchi; Y Sakaguchi; K Mazuda; M Yamakawa; J Yoshitake; S Takahashi
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

4.  Postperfusion energy metabolism of steatotic graft and its relation to early graft viability following liver transplantation.

Authors:  C Miki; K Iriyama; D F Mirza; A D Mayer; J A Buckels; H Suzuki; P McMaster
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

5.  Markers of cellular dysoxia during orthotopic liver transplantation in pigs.

Authors:  A de Jaeger; F Proulx; T Yandza; M A Dugas; B Boeuf; A Manika; J Lacroix; M Lambert
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

6.  Pretransplant assessment of human liver grafts by plasma lecithin: cholesterol acyltransferase (LCAT) activity in multiple organ donors.

Authors:  M Shimada; K Yanaga; H Higashi; L Makowka; S Kakizoe; T E Starzl
Journal:  Transpl Int       Date:  1992-03       Impact factor: 3.782

Review 7.  Liver transplantation (1).

Authors:  T E Starzl; A J Demetris; D Van Thiel
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

8.  Survival from hepatic transplantation. Relationship of protein synthesis to histological abnormalities in patient selection and postoperative management.

Authors:  R L Jenkins; G H Clowes; S Bosari; R H Pearl; U Khettry; C Trey
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

9.  Score-aided decision making in patients with severe liver damage after hepatic transplantation.

Authors:  G Gubernatis; G Tusch; B Ringe; H Bunzendahl; R Pichlmayr
Journal:  World J Surg       Date:  1989 May-Jun       Impact factor: 3.352

10.  Non-isotopic tyrosine kinetics using an alanyl-tyrosine dipeptide to assess graft function in liver transplant recipients - a pilot study.

Authors:  Claus G Krenn; Herwig Pokorny; Klaus Hoerauf; Josef Stark; Erich Roth; Heinz Steltzer; Wilfred Druml
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.